National Institute of Nursing Research; Notice of Closed Meeting, 63997-63998 [2013-25059]

Download as PDF Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices Addiction Research Programs, National Institutes of Health, HHS) Dated: October 21, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–25056 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee; Urology Subcommittee Workshop The Urology Subcommittee of the Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee (KUHICC) will hold a 1-day workshop on November 4, 2013. The workshop will be open to the public, with attendance limited to space available. SUMMARY: The workshop will be held on November 4, 2013, from 8:00 a.m. to 3:30 p.m. Requests for registration must occur 7 days prior to the workshop. DATES: The workshop will be at the National Institutes of Health, Office of Research on Women’s Health, Room 401, 6707 Democracy Boulevard, Rockville, MD 20817. ADDRESSES: FOR FURTHER INFORMATION CONTACT: For further information concerning this workshop, contact Dr. Tamara Bavendam, Co-Chair, Kidney, Urologic, and Hematologic Diseases Interagency Coordinating Committee—Urology Subcommittee, National Institute of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Bethesda, Room 615, MSC 5458, Bethesda, MD 20892–5458, telephone: 301–594–4733; email: tamara.bavendam@nih.gov. The KUHICC facilitates cooperation, communication, and collaboration on kidney, urologic, and hematologic diseases among government entities. The November 4, 2013, workshop held by the KUHICC Urology Subcommittee, also called the ‘‘Urology Interagency Coordinating Committee (UICC), will discuss research needs and new directions in women’s urologic health that can assist the NIDDK in development of a new Women’s Urologic Health Research Program. An agenda for this workshop is available by contacting Dr. Tamara Bavendam, email: tamara.bavendam@nih.gov. emcdonald on DSK67QTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Mar<15>2010 17:55 Oct 24, 2013 Jkt 232001 63997 Any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Because of time constraints for the workshop, there will not be time on the agenda for oral comments from members of the public. Please note that seating is limited and attendance will be first-come, firstserved. Non-federal individuals planning to attend the workshop should register by email to Dr. Tamara Bavendam, email: tamara.bavendam@ nih.gov and John Hare, The Scientific Consulting Group, Inc. (jhare@ scgcorp.com) after October 15, 2013. Please put ‘‘Registration UICC Nov 4 Meeting’’ in the subject line. Request for registration should occur at least 7 days prior to the workshop. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should inform the Contact Person listed below at least 10 days in advance of the workshop. Emphasis Panel; Autoimmunity Centers of Excellence, Basic and Clinical Components. Date: November 18–19, 2013. Time: November 18, 2013, 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Time: November 19, 2013, 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Paul A. Amstad, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–7098, pamstad@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: September 30, 2013. Griffin P. Rodgers, Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2013–25278 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Dated: October 21, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–25029 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health National Institute of Nursing Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research Special Emphasis Panel; Training and Career Development. Date: November 7, 2013. Time: 3:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, Suite 703K, 6701 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Yujing Liu, Ph.D., MD, Chief, Office of Review, Division of E:\FR\FM\25OCN1.SGM 25OCN1 63998 Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices Extramural Activities, National Institute of Nursing Research, National Institutes of Health, 6701 Democracy Blvd., Suite 703K, Bethesda, MD 20892, (301) 451–5152, yujing_ liu@nih.gov. This meeting notice is being published less than 15 days in advance of the meeting due to the Government shutdown of October 2013. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: October 21, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–25059 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting emcdonald on DSK67QTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01). Date: November 6, 2013. Time: 11:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Jay R Radke, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, Room 2217, 6700B Rockledge Drive MDS–7616, Bethesda, MD 20892–7616, 301–496–2550, jay.radke@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) VerDate Mar<15>2010 17:55 Oct 24, 2013 Jkt 232001 Dated: October 21, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–25030 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; NIBIB P30 Review 2014/05. Date: January 28, 2014. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, Suite 920, 6707 Democracy Boulevard, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 6707 Democracy Boulevard, Suite 957, Bethesda, MD 20892, 301–496–4773, zhour@mail.nih.gov. Dated: October 21, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–25032 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Office of AIDS Research Advisory Council. PO 00000 Frm 00040 Fmt 4703 Sfmt 9990 The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Office of AIDS Research Advisory Council. Date: November 14, 2013. Time: 8:30 a.m. to 5:00 p.m. Agenda: The theme of the Office of AIDS Research Advisory Council (OARAC) meeting will be NIH AIDS Priority-Setting in an Era of Budget Constraint. The OARAC will devote the full one-day meeting to reviewing key areas of the portfolio with presentations and discussions led by leaders in each scientific area including AIDS vaccines, microbicides, therapeutics research, behavioral research, disease progression/ comorbidities, and research toward a cure. An update will be provided on the latest changes made to the federal treatment and prevention guidelines by the OARAC Working Groups responsible for the guidelines. Place: National Institutes of Health, 5635 Fishers Lane Conference Center, Terrace Level, Suite T–500, Rockville, MD 20852. Contact Person: Robert Eisinger, Ph.D., Executive Secretary, Director of Scientific And Program Operations, Office of Aids Research, Office of The DirectoR, NIH, 5635 Fishers Lane, MSC 9310, Suite 400, Rockville, MD 20852, (301) 496–0357; be4y@ nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.oar.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: October 21, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–25027 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Pages 63997-63998]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25059]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

 National Institutes of Health


National Institute of Nursing Research; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Nursing Research 
Special Emphasis Panel; Training and Career Development.
    Date: November 7, 2013.
    Time: 3:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, Suite 
703K, 6701 Democracy Boulevard, Bethesda, MD 20892, (Telephone 
Conference Call).
    Contact Person: Yujing Liu, Ph.D., MD, Chief, Office of Review, 
Division of

[[Page 63998]]

Extramural Activities, National Institute of Nursing Research, 
National Institutes of Health, 6701 Democracy Blvd., Suite 703K, 
Bethesda, MD 20892, (301) 451-5152, yujing_liu@nih.gov.
    This meeting notice is being published less than 15 days in 
advance of the meeting due to the Government shutdown of October 
2013.

(Catalogue of Federal Domestic Assistance Program Nos. 93.361, 
Nursing Research, National Institutes of Health, HHS)

    Dated: October 21, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-25059 Filed 10-24-13; 8:45 am]
BILLING CODE 4140-01-P